- Combined tipranavir and enfuvirtide use associated with higher plasma tipranavir concentrations but not with increased hepatotoxicity: sub-analysis from RESIST. Raffi, F., Battegay, M., Rusconi, S., Opravil, M., Blick, G., Steigbigel, R.T., Kraft, M., Neubacher, D., Sabo, J.P. AIDS (2007)